Procoagulatory state in inflammatory bowel diseases is promoted by impaired intestinal barrier function

Luca Pastorelli, Elena Dozio, Laura Francesca Pisani, Massimo Boscolo-Anzoletti, Elena Vianello, Nadia Munizio, Luisa Spina, Gian Eugenio Tontini, Flora Peyvandi, Massimiliano Marco Corsi Romanelli, Maurizio Vecchi

Research output: Contribution to journalArticle

Abstract

Inflammatory and immune mediated disorders are risk factors for arterial and venous thromboembolism. Inflammatory bowel diseases (IBD) confer an even greater risk of thromboembolic events than other inflammatory conditions. It has been shown that IBD patients display defective intestinal barrier functions. Thus, pathogen-associated molecular patterns (PAMPs) coming from the intestinal bacterial burden might reach systemic circulation and activate innate immunity receptors on endothelial cells and platelets, promoting a procoagulative state. Aim of the study was to test this hypothesis, correlating the presence of circulating PAMPs with the activation of innate immune system and the activation of the coagulatory cascade in IBD patients. Specifically, we studied lipopolysaccharide (LPS), Toll-like receptor (TLR) 2, TLR4, and markers of activated coagulation (i.e., D-Dimer and prothrombin fragment F1 + 2) in the serum and plasma of IBD patients. We found that LPS levels are increased in IBD and correlate with TLR4 concentrations; although a mild correlation between LPS and CRP levels was detected, clinical disease activity does not appear to influence circulating LPS. Instead, serum LPS correlates with both D-Dimer and F1 + 2 measurements. Taken together, our data support the role of an impairment of intestinal barrier in triggering the activation of the coagulatory cascade in IBD.

Original languageEnglish
Article number189341
JournalGastroenterology Research and Practice
Volume2015
DOIs
Publication statusPublished - 2015

Fingerprint

Inflammatory Bowel Diseases
Lipopolysaccharides
Toll-Like Receptor 2
Immune System Diseases
Venous Thromboembolism
Serum
Innate Immunity
Immune System
Blood Platelets
Endothelial Cells

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Procoagulatory state in inflammatory bowel diseases is promoted by impaired intestinal barrier function. / Pastorelli, Luca; Dozio, Elena; Pisani, Laura Francesca; Boscolo-Anzoletti, Massimo; Vianello, Elena; Munizio, Nadia; Spina, Luisa; Tontini, Gian Eugenio; Peyvandi, Flora; Corsi Romanelli, Massimiliano Marco; Vecchi, Maurizio.

In: Gastroenterology Research and Practice, Vol. 2015, 189341, 2015.

Research output: Contribution to journalArticle

Pastorelli, Luca ; Dozio, Elena ; Pisani, Laura Francesca ; Boscolo-Anzoletti, Massimo ; Vianello, Elena ; Munizio, Nadia ; Spina, Luisa ; Tontini, Gian Eugenio ; Peyvandi, Flora ; Corsi Romanelli, Massimiliano Marco ; Vecchi, Maurizio. / Procoagulatory state in inflammatory bowel diseases is promoted by impaired intestinal barrier function. In: Gastroenterology Research and Practice. 2015 ; Vol. 2015.
@article{7c8fd7837e8b4cafbd478b1fef361577,
title = "Procoagulatory state in inflammatory bowel diseases is promoted by impaired intestinal barrier function",
abstract = "Inflammatory and immune mediated disorders are risk factors for arterial and venous thromboembolism. Inflammatory bowel diseases (IBD) confer an even greater risk of thromboembolic events than other inflammatory conditions. It has been shown that IBD patients display defective intestinal barrier functions. Thus, pathogen-associated molecular patterns (PAMPs) coming from the intestinal bacterial burden might reach systemic circulation and activate innate immunity receptors on endothelial cells and platelets, promoting a procoagulative state. Aim of the study was to test this hypothesis, correlating the presence of circulating PAMPs with the activation of innate immune system and the activation of the coagulatory cascade in IBD patients. Specifically, we studied lipopolysaccharide (LPS), Toll-like receptor (TLR) 2, TLR4, and markers of activated coagulation (i.e., D-Dimer and prothrombin fragment F1 + 2) in the serum and plasma of IBD patients. We found that LPS levels are increased in IBD and correlate with TLR4 concentrations; although a mild correlation between LPS and CRP levels was detected, clinical disease activity does not appear to influence circulating LPS. Instead, serum LPS correlates with both D-Dimer and F1 + 2 measurements. Taken together, our data support the role of an impairment of intestinal barrier in triggering the activation of the coagulatory cascade in IBD.",
author = "Luca Pastorelli and Elena Dozio and Pisani, {Laura Francesca} and Massimo Boscolo-Anzoletti and Elena Vianello and Nadia Munizio and Luisa Spina and Tontini, {Gian Eugenio} and Flora Peyvandi and {Corsi Romanelli}, {Massimiliano Marco} and Maurizio Vecchi",
year = "2015",
doi = "10.1155/2015/189341",
language = "English",
volume = "2015",
journal = "Gastroenterology Research and Practice",
issn = "1687-6121",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Procoagulatory state in inflammatory bowel diseases is promoted by impaired intestinal barrier function

AU - Pastorelli, Luca

AU - Dozio, Elena

AU - Pisani, Laura Francesca

AU - Boscolo-Anzoletti, Massimo

AU - Vianello, Elena

AU - Munizio, Nadia

AU - Spina, Luisa

AU - Tontini, Gian Eugenio

AU - Peyvandi, Flora

AU - Corsi Romanelli, Massimiliano Marco

AU - Vecchi, Maurizio

PY - 2015

Y1 - 2015

N2 - Inflammatory and immune mediated disorders are risk factors for arterial and venous thromboembolism. Inflammatory bowel diseases (IBD) confer an even greater risk of thromboembolic events than other inflammatory conditions. It has been shown that IBD patients display defective intestinal barrier functions. Thus, pathogen-associated molecular patterns (PAMPs) coming from the intestinal bacterial burden might reach systemic circulation and activate innate immunity receptors on endothelial cells and platelets, promoting a procoagulative state. Aim of the study was to test this hypothesis, correlating the presence of circulating PAMPs with the activation of innate immune system and the activation of the coagulatory cascade in IBD patients. Specifically, we studied lipopolysaccharide (LPS), Toll-like receptor (TLR) 2, TLR4, and markers of activated coagulation (i.e., D-Dimer and prothrombin fragment F1 + 2) in the serum and plasma of IBD patients. We found that LPS levels are increased in IBD and correlate with TLR4 concentrations; although a mild correlation between LPS and CRP levels was detected, clinical disease activity does not appear to influence circulating LPS. Instead, serum LPS correlates with both D-Dimer and F1 + 2 measurements. Taken together, our data support the role of an impairment of intestinal barrier in triggering the activation of the coagulatory cascade in IBD.

AB - Inflammatory and immune mediated disorders are risk factors for arterial and venous thromboembolism. Inflammatory bowel diseases (IBD) confer an even greater risk of thromboembolic events than other inflammatory conditions. It has been shown that IBD patients display defective intestinal barrier functions. Thus, pathogen-associated molecular patterns (PAMPs) coming from the intestinal bacterial burden might reach systemic circulation and activate innate immunity receptors on endothelial cells and platelets, promoting a procoagulative state. Aim of the study was to test this hypothesis, correlating the presence of circulating PAMPs with the activation of innate immune system and the activation of the coagulatory cascade in IBD patients. Specifically, we studied lipopolysaccharide (LPS), Toll-like receptor (TLR) 2, TLR4, and markers of activated coagulation (i.e., D-Dimer and prothrombin fragment F1 + 2) in the serum and plasma of IBD patients. We found that LPS levels are increased in IBD and correlate with TLR4 concentrations; although a mild correlation between LPS and CRP levels was detected, clinical disease activity does not appear to influence circulating LPS. Instead, serum LPS correlates with both D-Dimer and F1 + 2 measurements. Taken together, our data support the role of an impairment of intestinal barrier in triggering the activation of the coagulatory cascade in IBD.

UR - http://www.scopus.com/inward/record.url?scp=84924109692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924109692&partnerID=8YFLogxK

U2 - 10.1155/2015/189341

DO - 10.1155/2015/189341

M3 - Article

AN - SCOPUS:84924109692

VL - 2015

JO - Gastroenterology Research and Practice

JF - Gastroenterology Research and Practice

SN - 1687-6121

M1 - 189341

ER -